Literature DB >> 9295201

Opioid receptors on peripheral sensory axons.

R E Coggeshall1, S Zhou, S M Carlton.   

Abstract

Opioid receptors have been demonstrated by light microscopic techniques in fine cutaneous nerves in naive animals. The present study extends these findings by showing that 29 and 38% of unmyelinated cutaneous sensory axons can be immunostained for mu- or delta-opioid receptors respectively. Local cutaneous injection of DAMGO, a mu-opioid ligand, ameliorates the nociceptive behaviors caused by local cutaneous injection of glutamate, a purely nociceptive chemical stimulus showing that the mu-receptors are functional. By contrast the delta-opioid ligand [2-D-penicillamine, 5-D-penicillamine]enkephalin (DPDPE) had no effect on these behaviors. These findings indicate a wider function for opioid receptors in naive animals than previously envisioned.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9295201     DOI: 10.1016/s0006-8993(97)00446-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  40 in total

1.  The Meissner corpuscle revised: a multiafferented mechanoreceptor with nociceptor immunochemical properties.

Authors:  M Paré; R Elde; J E Mazurkiewicz; A M Smith; F L Rice
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

Review 2.  Glutamate pharmacology and metabolism in peripheral primary afferents: physiological and pathophysiological mechanisms.

Authors:  Kenneth E Miller; E Matthew Hoffman; Mathura Sutharshan; Ruben Schechter
Journal:  Pharmacol Ther       Date:  2011-01-26       Impact factor: 12.310

Review 3.  Peripheral mechanisms of pain and analgesia.

Authors:  Christoph Stein; J David Clark; Uhtaek Oh; Michael R Vasko; George L Wilcox; Aaron C Overland; Todd W Vanderah; Robert H Spencer
Journal:  Brain Res Rev       Date:  2008-12-31

4.  Opioid tolerance development: a pharmacokinetic/pharmacodynamic perspective.

Authors:  Emily O Dumas; Gary M Pollack
Journal:  AAPS J       Date:  2008-11-07       Impact factor: 4.009

5.  Mu opioid receptor expression is increased in inflammatory bowel diseases: implications for homeostatic intestinal inflammation.

Authors:  D Philippe; D Chakass; X Thuru; P Zerbib; A Tsicopoulos; K Geboes; P Bulois; M Breisse; H Vorng; J Gay; J-F Colombel; P Desreumaux; M Chamaillard
Journal:  Gut       Date:  2005-11-18       Impact factor: 23.059

6.  Influence of intramuscular heat stimulation on modulation of nociception: complex role of central opioid receptors in descending facilitation and inhibition.

Authors:  Hao-Jun You; Jing Lei; Gang Ye; Xiao-Li Fan; Qiang Li
Journal:  J Physiol       Date:  2014-07-18       Impact factor: 5.182

7.  Primary afferent neurons express functional delta opioid receptors in inflamed skin.

Authors:  Jill-Desiree Brederson; Christopher N Honda
Journal:  Brain Res       Date:  2015-04-22       Impact factor: 3.252

8.  Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation.

Authors:  David Philippe; Laurent Dubuquoy; Hervé Groux; Valérie Brun; Myriam Tran Van Chuoï-Mariot; Claire Gaveriaux-Ruff; Jean-Frédéric Colombel; Brigitte L Kieffer; Pierre Desreumaux
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

9.  Effects of herpes simplex virus vector-mediated enkephalin gene therapy on bladder overactivity and nociception.

Authors:  Hitoshi Yokoyama; Tomohiko Oguchi; William F Goins; James R Goss; Osamu Nishizawa; William C de Groat; Darren Wolfe; David M Krisky; Joseph C Glorioso; Naoki Yoshimura
Journal:  Hum Gene Ther       Date:  2013-02-14       Impact factor: 5.695

10.  Pre-emptive analgesia and its supraspinal mechanisms: enhanced descending inhibition and decreased descending facilitation by dexmedetomidine.

Authors:  Hao-Jun You; Jing Lei; Ying Xiao; Gang Ye; Zhi-Hong Sun; Lan Yang; Nan Niu
Journal:  J Physiol       Date:  2016-02-04       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.